nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Trimethadione—epilepsy syndrome	0.0653	0.17	CbGbCtD
Epoprostenol—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0614	0.16	CbGbCtD
Epoprostenol—CYP2C9—Carbamazepine—epilepsy syndrome	0.0441	0.115	CbGbCtD
Epoprostenol—CYP2C9—Primidone—epilepsy syndrome	0.0412	0.107	CbGbCtD
Epoprostenol—CYP2C9—Phenytoin—epilepsy syndrome	0.0395	0.103	CbGbCtD
Epoprostenol—CYP2C9—Propofol—epilepsy syndrome	0.0369	0.0962	CbGbCtD
Epoprostenol—CYP2C9—Phenobarbital—epilepsy syndrome	0.0352	0.092	CbGbCtD
Epoprostenol—CYP2C9—Diazepam—epilepsy syndrome	0.0334	0.0872	CbGbCtD
Epoprostenol—CYP2C9—Valproic Acid—epilepsy syndrome	0.0263	0.0687	CbGbCtD
Epoprostenol—PTGIR—hindbrain—epilepsy syndrome	0.00475	0.0952	CbGeAlD
Epoprostenol—P2RY12—forebrain—epilepsy syndrome	0.00412	0.0826	CbGeAlD
Epoprostenol—PTGIR—brainstem—epilepsy syndrome	0.00272	0.0546	CbGeAlD
Epoprostenol—PTGIR—forebrain—epilepsy syndrome	0.00263	0.0527	CbGeAlD
Epoprostenol—PTGIS—head—epilepsy syndrome	0.00262	0.0525	CbGeAlD
Epoprostenol—PTGIS—nervous system—epilepsy syndrome	0.00248	0.0498	CbGeAlD
Epoprostenol—PTGER1—head—epilepsy syndrome	0.00244	0.0488	CbGeAlD
Epoprostenol—PTGIR—telencephalon—epilepsy syndrome	0.00242	0.0484	CbGeAlD
Epoprostenol—PTGIS—central nervous system—epilepsy syndrome	0.00239	0.0479	CbGeAlD
Epoprostenol—P2RY12—head—epilepsy syndrome	0.00236	0.0473	CbGeAlD
Epoprostenol—PTGER1—nervous system—epilepsy syndrome	0.00231	0.0463	CbGeAlD
Epoprostenol—P2RY12—nervous system—epilepsy syndrome	0.00224	0.0448	CbGeAlD
Epoprostenol—PTGER1—central nervous system—epilepsy syndrome	0.00222	0.0446	CbGeAlD
Epoprostenol—P2RY12—central nervous system—epilepsy syndrome	0.00215	0.0432	CbGeAlD
Epoprostenol—PTGIS—brain—epilepsy syndrome	0.0019	0.0381	CbGeAlD
Epoprostenol—P2RY12—brain—epilepsy syndrome	0.00171	0.0343	CbGeAlD
Epoprostenol—PTGIR—spinal cord—epilepsy syndrome	0.00169	0.0339	CbGeAlD
Epoprostenol—PTGIR—head—epilepsy syndrome	0.0015	0.0302	CbGeAlD
Epoprostenol—PTGIR—nervous system—epilepsy syndrome	0.00143	0.0286	CbGeAlD
Epoprostenol—PTGIR—central nervous system—epilepsy syndrome	0.00137	0.0275	CbGeAlD
Epoprostenol—PTGIR—cerebellum—epilepsy syndrome	0.00134	0.0269	CbGeAlD
Epoprostenol—Dinoprostone—SLCO1A2—epilepsy syndrome	0.00114	0.535	CrCbGaD
Epoprostenol—PTGIR—brain—epilepsy syndrome	0.00109	0.0219	CbGeAlD
Epoprostenol—Dinoprostone—CYP11A1—epilepsy syndrome	0.000996	0.465	CrCbGaD
Epoprostenol—Skin disorder—Valproic Acid—epilepsy syndrome	0.000115	0.000314	CcSEcCtD
Epoprostenol—Oedema peripheral—Topiramate—epilepsy syndrome	0.000115	0.000313	CcSEcCtD
Epoprostenol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000115	0.000313	CcSEcCtD
Epoprostenol—Cough—Pregabalin—epilepsy syndrome	0.000115	0.000313	CcSEcCtD
Epoprostenol—Pruritus—Phenytoin—epilepsy syndrome	0.000115	0.000312	CcSEcCtD
Epoprostenol—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000115	0.000312	CcSEcCtD
Epoprostenol—Nausea—Levetiracetam—epilepsy syndrome	0.000115	0.000312	CcSEcCtD
Epoprostenol—Rash—Vigabatrin—epilepsy syndrome	0.000115	0.000311	CcSEcCtD
Epoprostenol—Dizziness—Felbamate—epilepsy syndrome	0.000114	0.000311	CcSEcCtD
Epoprostenol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000114	0.000311	CcSEcCtD
Epoprostenol—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000114	0.00031	CcSEcCtD
Epoprostenol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000114	0.00031	CcSEcCtD
Epoprostenol—Headache—Vigabatrin—epilepsy syndrome	0.000114	0.000309	CcSEcCtD
Epoprostenol—Vomiting—Diazepam—epilepsy syndrome	0.000114	0.000309	CcSEcCtD
Epoprostenol—Anorexia—Valproic Acid—epilepsy syndrome	0.000113	0.000308	CcSEcCtD
Epoprostenol—Tremor—Gabapentin—epilepsy syndrome	0.000113	0.000308	CcSEcCtD
Epoprostenol—Rash—Diazepam—epilepsy syndrome	0.000113	0.000307	CcSEcCtD
Epoprostenol—Dermatitis—Diazepam—epilepsy syndrome	0.000113	0.000306	CcSEcCtD
Epoprostenol—Chest pain—Pregabalin—epilepsy syndrome	0.000112	0.000305	CcSEcCtD
Epoprostenol—Myalgia—Pregabalin—epilepsy syndrome	0.000112	0.000305	CcSEcCtD
Epoprostenol—Arthralgia—Pregabalin—epilepsy syndrome	0.000112	0.000305	CcSEcCtD
Epoprostenol—Dizziness—Zonisamide—epilepsy syndrome	0.000112	0.000305	CcSEcCtD
Epoprostenol—Headache—Diazepam—epilepsy syndrome	0.000112	0.000305	CcSEcCtD
Epoprostenol—Anxiety—Pregabalin—epilepsy syndrome	0.000112	0.000304	CcSEcCtD
Epoprostenol—Diarrhoea—Clonazepam—epilepsy syndrome	0.000112	0.000304	CcSEcCtD
Epoprostenol—Anaemia—Gabapentin—epilepsy syndrome	0.000112	0.000304	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000111	0.000303	CcSEcCtD
Epoprostenol—Hypotension—Valproic Acid—epilepsy syndrome	0.000111	0.000302	CcSEcCtD
Epoprostenol—Asthenia—Carbamazepine—epilepsy syndrome	0.000111	0.000302	CcSEcCtD
Epoprostenol—Agitation—Gabapentin—epilepsy syndrome	0.000111	0.000302	CcSEcCtD
Epoprostenol—Diarrhoea—Phenytoin—epilepsy syndrome	0.000111	0.000302	CcSEcCtD
Epoprostenol—Nausea—Fosphenytoin—epilepsy syndrome	0.000111	0.000301	CcSEcCtD
Epoprostenol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00011	0.0003	CcSEcCtD
Epoprostenol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.00011	0.0003	CcSEcCtD
Epoprostenol—Vomiting—Felbamate—epilepsy syndrome	0.00011	0.000299	CcSEcCtD
Epoprostenol—Dry mouth—Pregabalin—epilepsy syndrome	0.00011	0.000298	CcSEcCtD
Epoprostenol—Pruritus—Carbamazepine—epilepsy syndrome	0.00011	0.000298	CcSEcCtD
Epoprostenol—Rash—Felbamate—epilepsy syndrome	0.000109	0.000297	CcSEcCtD
Epoprostenol—Dermatitis—Felbamate—epilepsy syndrome	0.000109	0.000297	CcSEcCtD
Epoprostenol—Headache—Felbamate—epilepsy syndrome	0.000108	0.000295	CcSEcCtD
Epoprostenol—Confusional state—Pregabalin—epilepsy syndrome	0.000108	0.000295	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000108	0.000295	CcSEcCtD
Epoprostenol—Flushing—Topiramate—epilepsy syndrome	0.000108	0.000295	CcSEcCtD
Epoprostenol—Cardiac disorder—Topiramate—epilepsy syndrome	0.000108	0.000295	CcSEcCtD
Epoprostenol—Syncope—Gabapentin—epilepsy syndrome	0.000108	0.000295	CcSEcCtD
Epoprostenol—Dizziness—Clonazepam—epilepsy syndrome	0.000108	0.000294	CcSEcCtD
Epoprostenol—Nausea—Vigabatrin—epilepsy syndrome	0.000108	0.000293	CcSEcCtD
Epoprostenol—Vomiting—Zonisamide—epilepsy syndrome	0.000108	0.000293	CcSEcCtD
Epoprostenol—Insomnia—Valproic Acid—epilepsy syndrome	0.000108	0.000292	CcSEcCtD
Epoprostenol—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000107	0.000292	CcSEcCtD
Epoprostenol—Oedema—Pregabalin—epilepsy syndrome	0.000107	0.000292	CcSEcCtD
Epoprostenol—Asthenia—Lamotrigine—epilepsy syndrome	0.000107	0.000292	CcSEcCtD
Epoprostenol—Dizziness—Phenytoin—epilepsy syndrome	0.000107	0.000292	CcSEcCtD
Epoprostenol—Rash—Zonisamide—epilepsy syndrome	0.000107	0.000291	CcSEcCtD
Epoprostenol—Infection—Pregabalin—epilepsy syndrome	0.000107	0.00029	CcSEcCtD
Epoprostenol—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000107	0.00029	CcSEcCtD
Epoprostenol—Palpitations—Gabapentin—epilepsy syndrome	0.000107	0.00029	CcSEcCtD
Epoprostenol—Dermatitis—Zonisamide—epilepsy syndrome	0.000107	0.00029	CcSEcCtD
Epoprostenol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000107	0.00029	CcSEcCtD
Epoprostenol—Nausea—Diazepam—epilepsy syndrome	0.000106	0.000289	CcSEcCtD
Epoprostenol—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000106	0.000289	CcSEcCtD
Epoprostenol—Headache—Zonisamide—epilepsy syndrome	0.000106	0.000289	CcSEcCtD
Epoprostenol—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000106	0.000288	CcSEcCtD
Epoprostenol—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000106	0.000288	CcSEcCtD
Epoprostenol—Angiopathy—Topiramate—epilepsy syndrome	0.000106	0.000288	CcSEcCtD
Epoprostenol—Pruritus—Lamotrigine—epilepsy syndrome	0.000106	0.000288	CcSEcCtD
Epoprostenol—Shock—Pregabalin—epilepsy syndrome	0.000106	0.000288	CcSEcCtD
Epoprostenol—Somnolence—Valproic Acid—epilepsy syndrome	0.000106	0.000287	CcSEcCtD
Epoprostenol—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000105	0.000287	CcSEcCtD
Epoprostenol—Cough—Gabapentin—epilepsy syndrome	0.000105	0.000287	CcSEcCtD
Epoprostenol—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000105	0.000286	CcSEcCtD
Epoprostenol—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000105	0.000286	CcSEcCtD
Epoprostenol—Tachycardia—Pregabalin—epilepsy syndrome	0.000105	0.000285	CcSEcCtD
Epoprostenol—Chills—Topiramate—epilepsy syndrome	0.000105	0.000285	CcSEcCtD
Epoprostenol—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000105	0.000285	CcSEcCtD
Epoprostenol—Skin disorder—Pregabalin—epilepsy syndrome	0.000104	0.000284	CcSEcCtD
Epoprostenol—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000104	0.000283	CcSEcCtD
Epoprostenol—Vomiting—Clonazepam—epilepsy syndrome	0.000104	0.000282	CcSEcCtD
Epoprostenol—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000103	0.000281	CcSEcCtD
Epoprostenol—Vomiting—Phenytoin—epilepsy syndrome	0.000103	0.00028	CcSEcCtD
Epoprostenol—Rash—Clonazepam—epilepsy syndrome	0.000103	0.00028	CcSEcCtD
Epoprostenol—Dermatitis—Clonazepam—epilepsy syndrome	0.000103	0.00028	CcSEcCtD
Epoprostenol—Myalgia—Gabapentin—epilepsy syndrome	0.000103	0.00028	CcSEcCtD
Epoprostenol—Arthralgia—Gabapentin—epilepsy syndrome	0.000103	0.00028	CcSEcCtD
Epoprostenol—Chest pain—Gabapentin—epilepsy syndrome	0.000103	0.00028	CcSEcCtD
Epoprostenol—Nausea—Felbamate—epilepsy syndrome	0.000103	0.00028	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000103	0.000279	CcSEcCtD
Epoprostenol—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000103	0.000279	CcSEcCtD
Epoprostenol—Fatigue—Valproic Acid—epilepsy syndrome	0.000103	0.000279	CcSEcCtD
Epoprostenol—Anxiety—Gabapentin—epilepsy syndrome	0.000102	0.000279	CcSEcCtD
Epoprostenol—Anorexia—Pregabalin—epilepsy syndrome	0.000102	0.000279	CcSEcCtD
Epoprostenol—Dizziness—Carbamazepine—epilepsy syndrome	0.000102	0.000278	CcSEcCtD
Epoprostenol—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000102	0.000278	CcSEcCtD
Epoprostenol—Headache—Clonazepam—epilepsy syndrome	0.000102	0.000278	CcSEcCtD
Epoprostenol—Rash—Phenytoin—epilepsy syndrome	0.000102	0.000278	CcSEcCtD
Epoprostenol—Mental disorder—Topiramate—epilepsy syndrome	0.000102	0.000278	CcSEcCtD
Epoprostenol—Dermatitis—Phenytoin—epilepsy syndrome	0.000102	0.000278	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000102	0.000278	CcSEcCtD
Epoprostenol—Rash—Oxcarbazepine—epilepsy syndrome	0.000102	0.000277	CcSEcCtD
Epoprostenol—Pain—Valproic Acid—epilepsy syndrome	0.000102	0.000277	CcSEcCtD
Epoprostenol—Constipation—Valproic Acid—epilepsy syndrome	0.000102	0.000277	CcSEcCtD
Epoprostenol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000102	0.000276	CcSEcCtD
Epoprostenol—Headache—Phenytoin—epilepsy syndrome	0.000102	0.000276	CcSEcCtD
Epoprostenol—Headache—Oxcarbazepine—epilepsy syndrome	0.000101	0.000275	CcSEcCtD
Epoprostenol—Nausea—Zonisamide—epilepsy syndrome	0.000101	0.000274	CcSEcCtD
Epoprostenol—Dry mouth—Gabapentin—epilepsy syndrome	0.000101	0.000273	CcSEcCtD
Epoprostenol—Hypotension—Pregabalin—epilepsy syndrome	0.0001	0.000273	CcSEcCtD
Epoprostenol—Flatulence—Topiramate—epilepsy syndrome	0.0001	0.000272	CcSEcCtD
Epoprostenol—Tension—Topiramate—epilepsy syndrome	9.97e-05	0.000271	CcSEcCtD
Epoprostenol—Confusional state—Gabapentin—epilepsy syndrome	9.94e-05	0.00027	CcSEcCtD
Epoprostenol—Dizziness—Lamotrigine—epilepsy syndrome	9.9e-05	0.000269	CcSEcCtD
Epoprostenol—Nervousness—Topiramate—epilepsy syndrome	9.87e-05	0.000268	CcSEcCtD
Epoprostenol—Oedema—Gabapentin—epilepsy syndrome	9.86e-05	0.000268	CcSEcCtD
Epoprostenol—Anaphylactic shock—Gabapentin—epilepsy syndrome	9.86e-05	0.000268	CcSEcCtD
Epoprostenol—Vomiting—Carbamazepine—epilepsy syndrome	9.84e-05	0.000268	CcSEcCtD
Epoprostenol—Back pain—Topiramate—epilepsy syndrome	9.83e-05	0.000267	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.79e-05	0.000266	CcSEcCtD
Epoprostenol—Infection—Gabapentin—epilepsy syndrome	9.79e-05	0.000266	CcSEcCtD
Epoprostenol—Muscle spasms—Topiramate—epilepsy syndrome	9.77e-05	0.000266	CcSEcCtD
Epoprostenol—Rash—Carbamazepine—epilepsy syndrome	9.76e-05	0.000265	CcSEcCtD
Epoprostenol—Dermatitis—Carbamazepine—epilepsy syndrome	9.75e-05	0.000265	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.72e-05	0.000264	CcSEcCtD
Epoprostenol—Insomnia—Pregabalin—epilepsy syndrome	9.72e-05	0.000264	CcSEcCtD
Epoprostenol—Nausea—Clonazepam—epilepsy syndrome	9.7e-05	0.000264	CcSEcCtD
Epoprostenol—Headache—Carbamazepine—epilepsy syndrome	9.7e-05	0.000264	CcSEcCtD
Epoprostenol—Shock—Gabapentin—epilepsy syndrome	9.7e-05	0.000264	CcSEcCtD
Epoprostenol—Nervous system disorder—Gabapentin—epilepsy syndrome	9.67e-05	0.000263	CcSEcCtD
Epoprostenol—Paraesthesia—Pregabalin—epilepsy syndrome	9.65e-05	0.000263	CcSEcCtD
Epoprostenol—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.65e-05	0.000262	CcSEcCtD
Epoprostenol—Nausea—Phenytoin—epilepsy syndrome	9.63e-05	0.000262	CcSEcCtD
Epoprostenol—Tachycardia—Gabapentin—epilepsy syndrome	9.62e-05	0.000262	CcSEcCtD
Epoprostenol—Dyspnoea—Pregabalin—epilepsy syndrome	9.58e-05	0.000261	CcSEcCtD
Epoprostenol—Nausea—Oxcarbazepine—epilepsy syndrome	9.58e-05	0.000261	CcSEcCtD
Epoprostenol—Skin disorder—Gabapentin—epilepsy syndrome	9.57e-05	0.00026	CcSEcCtD
Epoprostenol—Somnolence—Pregabalin—epilepsy syndrome	9.56e-05	0.00026	CcSEcCtD
Epoprostenol—Hyperhidrosis—Gabapentin—epilepsy syndrome	9.53e-05	0.000259	CcSEcCtD
Epoprostenol—Tremor—Topiramate—epilepsy syndrome	9.52e-05	0.000259	CcSEcCtD
Epoprostenol—Vomiting—Lamotrigine—epilepsy syndrome	9.51e-05	0.000259	CcSEcCtD
Epoprostenol—Urticaria—Valproic Acid—epilepsy syndrome	9.45e-05	0.000257	CcSEcCtD
Epoprostenol—Rash—Lamotrigine—epilepsy syndrome	9.43e-05	0.000257	CcSEcCtD
Epoprostenol—Dermatitis—Lamotrigine—epilepsy syndrome	9.43e-05	0.000256	CcSEcCtD
Epoprostenol—Body temperature increased—Valproic Acid—epilepsy syndrome	9.4e-05	0.000256	CcSEcCtD
Epoprostenol—Abdominal pain—Valproic Acid—epilepsy syndrome	9.4e-05	0.000256	CcSEcCtD
Epoprostenol—Anorexia—Gabapentin—epilepsy syndrome	9.4e-05	0.000256	CcSEcCtD
Epoprostenol—Anaemia—Topiramate—epilepsy syndrome	9.39e-05	0.000255	CcSEcCtD
Epoprostenol—Headache—Lamotrigine—epilepsy syndrome	9.37e-05	0.000255	CcSEcCtD
Epoprostenol—Decreased appetite—Pregabalin—epilepsy syndrome	9.34e-05	0.000254	CcSEcCtD
Epoprostenol—Agitation—Topiramate—epilepsy syndrome	9.34e-05	0.000254	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	9.28e-05	0.000252	CcSEcCtD
Epoprostenol—Fatigue—Pregabalin—epilepsy syndrome	9.27e-05	0.000252	CcSEcCtD
Epoprostenol—Hypotension—Gabapentin—epilepsy syndrome	9.21e-05	0.00025	CcSEcCtD
Epoprostenol—Nausea—Carbamazepine—epilepsy syndrome	9.2e-05	0.00025	CcSEcCtD
Epoprostenol—Constipation—Pregabalin—epilepsy syndrome	9.19e-05	0.00025	CcSEcCtD
Epoprostenol—Pain—Pregabalin—epilepsy syndrome	9.19e-05	0.00025	CcSEcCtD
Epoprostenol—Syncope—Topiramate—epilepsy syndrome	9.11e-05	0.000248	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.98e-05	0.000244	CcSEcCtD
Epoprostenol—Palpitations—Topiramate—epilepsy syndrome	8.98e-05	0.000244	CcSEcCtD
Epoprostenol—Loss of consciousness—Topiramate—epilepsy syndrome	8.93e-05	0.000243	CcSEcCtD
Epoprostenol—Insomnia—Gabapentin—epilepsy syndrome	8.92e-05	0.000242	CcSEcCtD
Epoprostenol—Nausea—Lamotrigine—epilepsy syndrome	8.89e-05	0.000242	CcSEcCtD
Epoprostenol—Cough—Topiramate—epilepsy syndrome	8.87e-05	0.000241	CcSEcCtD
Epoprostenol—Paraesthesia—Gabapentin—epilepsy syndrome	8.85e-05	0.000241	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.79e-05	0.000239	CcSEcCtD
Epoprostenol—Dyspnoea—Gabapentin—epilepsy syndrome	8.79e-05	0.000239	CcSEcCtD
Epoprostenol—Somnolence—Gabapentin—epilepsy syndrome	8.76e-05	0.000238	CcSEcCtD
Epoprostenol—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.76e-05	0.000238	CcSEcCtD
Epoprostenol—Dyspepsia—Gabapentin—epilepsy syndrome	8.68e-05	0.000236	CcSEcCtD
Epoprostenol—Chest pain—Topiramate—epilepsy syndrome	8.65e-05	0.000235	CcSEcCtD
Epoprostenol—Myalgia—Topiramate—epilepsy syndrome	8.65e-05	0.000235	CcSEcCtD
Epoprostenol—Arthralgia—Topiramate—epilepsy syndrome	8.65e-05	0.000235	CcSEcCtD
Epoprostenol—Anxiety—Topiramate—epilepsy syndrome	8.62e-05	0.000234	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	8.59e-05	0.000234	CcSEcCtD
Epoprostenol—Decreased appetite—Gabapentin—epilepsy syndrome	8.57e-05	0.000233	CcSEcCtD
Epoprostenol—Urticaria—Pregabalin—epilepsy syndrome	8.54e-05	0.000232	CcSEcCtD
Epoprostenol—Asthenia—Valproic Acid—epilepsy syndrome	8.53e-05	0.000232	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.51e-05	0.000231	CcSEcCtD
Epoprostenol—Fatigue—Gabapentin—epilepsy syndrome	8.5e-05	0.000231	CcSEcCtD
Epoprostenol—Body temperature increased—Pregabalin—epilepsy syndrome	8.5e-05	0.000231	CcSEcCtD
Epoprostenol—Abdominal pain—Pregabalin—epilepsy syndrome	8.5e-05	0.000231	CcSEcCtD
Epoprostenol—Dry mouth—Topiramate—epilepsy syndrome	8.46e-05	0.00023	CcSEcCtD
Epoprostenol—Pain—Gabapentin—epilepsy syndrome	8.43e-05	0.000229	CcSEcCtD
Epoprostenol—Constipation—Gabapentin—epilepsy syndrome	8.43e-05	0.000229	CcSEcCtD
Epoprostenol—Pruritus—Valproic Acid—epilepsy syndrome	8.41e-05	0.000229	CcSEcCtD
Epoprostenol—Confusional state—Topiramate—epilepsy syndrome	8.36e-05	0.000227	CcSEcCtD
Epoprostenol—Oedema—Topiramate—epilepsy syndrome	8.29e-05	0.000226	CcSEcCtD
Epoprostenol—Infection—Topiramate—epilepsy syndrome	8.24e-05	0.000224	CcSEcCtD
Epoprostenol—Shock—Topiramate—epilepsy syndrome	8.16e-05	0.000222	CcSEcCtD
Epoprostenol—Diarrhoea—Valproic Acid—epilepsy syndrome	8.14e-05	0.000221	CcSEcCtD
Epoprostenol—Nervous system disorder—Topiramate—epilepsy syndrome	8.13e-05	0.000221	CcSEcCtD
Epoprostenol—Thrombocytopenia—Topiramate—epilepsy syndrome	8.12e-05	0.000221	CcSEcCtD
Epoprostenol—Tachycardia—Topiramate—epilepsy syndrome	8.09e-05	0.00022	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	8.06e-05	0.000219	CcSEcCtD
Epoprostenol—Skin disorder—Topiramate—epilepsy syndrome	8.06e-05	0.000219	CcSEcCtD
Epoprostenol—Hyperhidrosis—Topiramate—epilepsy syndrome	8.02e-05	0.000218	CcSEcCtD
Epoprostenol—Hypersensitivity—Pregabalin—epilepsy syndrome	7.92e-05	0.000215	CcSEcCtD
Epoprostenol—Anorexia—Topiramate—epilepsy syndrome	7.91e-05	0.000215	CcSEcCtD
Epoprostenol—Dizziness—Valproic Acid—epilepsy syndrome	7.86e-05	0.000214	CcSEcCtD
Epoprostenol—Urticaria—Gabapentin—epilepsy syndrome	7.83e-05	0.000213	CcSEcCtD
Epoprostenol—Abdominal pain—Gabapentin—epilepsy syndrome	7.79e-05	0.000212	CcSEcCtD
Epoprostenol—Body temperature increased—Gabapentin—epilepsy syndrome	7.79e-05	0.000212	CcSEcCtD
Epoprostenol—Hypotension—Topiramate—epilepsy syndrome	7.75e-05	0.000211	CcSEcCtD
Epoprostenol—Asthenia—Pregabalin—epilepsy syndrome	7.71e-05	0.00021	CcSEcCtD
Epoprostenol—Pruritus—Pregabalin—epilepsy syndrome	7.61e-05	0.000207	CcSEcCtD
Epoprostenol—Vomiting—Valproic Acid—epilepsy syndrome	7.56e-05	0.000206	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.56e-05	0.000205	CcSEcCtD
Epoprostenol—Insomnia—Topiramate—epilepsy syndrome	7.5e-05	0.000204	CcSEcCtD
Epoprostenol—Rash—Valproic Acid—epilepsy syndrome	7.5e-05	0.000204	CcSEcCtD
Epoprostenol—Dermatitis—Valproic Acid—epilepsy syndrome	7.49e-05	0.000204	CcSEcCtD
Epoprostenol—Headache—Valproic Acid—epilepsy syndrome	7.45e-05	0.000203	CcSEcCtD
Epoprostenol—Paraesthesia—Topiramate—epilepsy syndrome	7.45e-05	0.000203	CcSEcCtD
Epoprostenol—Dyspnoea—Topiramate—epilepsy syndrome	7.39e-05	0.000201	CcSEcCtD
Epoprostenol—Somnolence—Topiramate—epilepsy syndrome	7.37e-05	0.0002	CcSEcCtD
Epoprostenol—Diarrhoea—Pregabalin—epilepsy syndrome	7.36e-05	0.0002	CcSEcCtD
Epoprostenol—Dyspepsia—Topiramate—epilepsy syndrome	7.3e-05	0.000199	CcSEcCtD
Epoprostenol—Hypersensitivity—Gabapentin—epilepsy syndrome	7.26e-05	0.000198	CcSEcCtD
Epoprostenol—Decreased appetite—Topiramate—epilepsy syndrome	7.21e-05	0.000196	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	7.16e-05	0.000195	CcSEcCtD
Epoprostenol—Fatigue—Topiramate—epilepsy syndrome	7.15e-05	0.000194	CcSEcCtD
Epoprostenol—Dizziness—Pregabalin—epilepsy syndrome	7.11e-05	0.000193	CcSEcCtD
Epoprostenol—Pain—Topiramate—epilepsy syndrome	7.09e-05	0.000193	CcSEcCtD
Epoprostenol—Constipation—Topiramate—epilepsy syndrome	7.09e-05	0.000193	CcSEcCtD
Epoprostenol—Asthenia—Gabapentin—epilepsy syndrome	7.07e-05	0.000192	CcSEcCtD
Epoprostenol—Nausea—Valproic Acid—epilepsy syndrome	7.06e-05	0.000192	CcSEcCtD
Epoprostenol—Pruritus—Gabapentin—epilepsy syndrome	6.97e-05	0.00019	CcSEcCtD
Epoprostenol—Vomiting—Pregabalin—epilepsy syndrome	6.83e-05	0.000186	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.78e-05	0.000184	CcSEcCtD
Epoprostenol—Rash—Pregabalin—epilepsy syndrome	6.78e-05	0.000184	CcSEcCtD
Epoprostenol—Dermatitis—Pregabalin—epilepsy syndrome	6.77e-05	0.000184	CcSEcCtD
Epoprostenol—Diarrhoea—Gabapentin—epilepsy syndrome	6.74e-05	0.000183	CcSEcCtD
Epoprostenol—Headache—Pregabalin—epilepsy syndrome	6.73e-05	0.000183	CcSEcCtD
Epoprostenol—Urticaria—Topiramate—epilepsy syndrome	6.59e-05	0.000179	CcSEcCtD
Epoprostenol—Body temperature increased—Topiramate—epilepsy syndrome	6.56e-05	0.000178	CcSEcCtD
Epoprostenol—Abdominal pain—Topiramate—epilepsy syndrome	6.56e-05	0.000178	CcSEcCtD
Epoprostenol—Dizziness—Gabapentin—epilepsy syndrome	6.52e-05	0.000177	CcSEcCtD
Epoprostenol—Nausea—Pregabalin—epilepsy syndrome	6.39e-05	0.000174	CcSEcCtD
Epoprostenol—Vomiting—Gabapentin—epilepsy syndrome	6.27e-05	0.00017	CcSEcCtD
Epoprostenol—Rash—Gabapentin—epilepsy syndrome	6.22e-05	0.000169	CcSEcCtD
Epoprostenol—Dermatitis—Gabapentin—epilepsy syndrome	6.21e-05	0.000169	CcSEcCtD
Epoprostenol—Headache—Gabapentin—epilepsy syndrome	6.18e-05	0.000168	CcSEcCtD
Epoprostenol—Hypersensitivity—Topiramate—epilepsy syndrome	6.11e-05	0.000166	CcSEcCtD
Epoprostenol—Asthenia—Topiramate—epilepsy syndrome	5.95e-05	0.000162	CcSEcCtD
Epoprostenol—Pruritus—Topiramate—epilepsy syndrome	5.87e-05	0.00016	CcSEcCtD
Epoprostenol—Nausea—Gabapentin—epilepsy syndrome	5.86e-05	0.000159	CcSEcCtD
Epoprostenol—Diarrhoea—Topiramate—epilepsy syndrome	5.67e-05	0.000154	CcSEcCtD
Epoprostenol—Dizziness—Topiramate—epilepsy syndrome	5.48e-05	0.000149	CcSEcCtD
Epoprostenol—Vomiting—Topiramate—epilepsy syndrome	5.27e-05	0.000143	CcSEcCtD
Epoprostenol—Rash—Topiramate—epilepsy syndrome	5.23e-05	0.000142	CcSEcCtD
Epoprostenol—Dermatitis—Topiramate—epilepsy syndrome	5.22e-05	0.000142	CcSEcCtD
Epoprostenol—Headache—Topiramate—epilepsy syndrome	5.2e-05	0.000141	CcSEcCtD
Epoprostenol—Nausea—Topiramate—epilepsy syndrome	4.93e-05	0.000134	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—CCR2—epilepsy syndrome	3.52e-05	0.000179	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NTRK2—epilepsy syndrome	3.52e-05	0.000179	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SST—epilepsy syndrome	3.52e-05	0.000179	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—DUSP6—epilepsy syndrome	3.49e-05	0.000177	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6ST—epilepsy syndrome	3.48e-05	0.000177	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR2A—epilepsy syndrome	3.46e-05	0.000176	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR2A—epilepsy syndrome	3.46e-05	0.000176	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS2—epilepsy syndrome	3.45e-05	0.000175	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADRA2A—epilepsy syndrome	3.45e-05	0.000175	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PLAT—epilepsy syndrome	3.43e-05	0.000174	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—SRC—epilepsy syndrome	3.38e-05	0.000171	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.34e-05	0.00017	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.34e-05	0.00017	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTK2B—epilepsy syndrome	3.33e-05	0.000169	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TSC1—epilepsy syndrome	3.33e-05	0.000169	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TSC1—epilepsy syndrome	3.33e-05	0.000169	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTK2B—epilepsy syndrome	3.33e-05	0.000169	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—BDKRB2—epilepsy syndrome	3.31e-05	0.000168	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL12—epilepsy syndrome	3.31e-05	0.000168	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—POMC—epilepsy syndrome	3.31e-05	0.000168	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PRKCB—epilepsy syndrome	3.3e-05	0.000167	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—VEGFA—epilepsy syndrome	3.29e-05	0.000167	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AGT—epilepsy syndrome	3.28e-05	0.000167	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AGT—epilepsy syndrome	3.28e-05	0.000167	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6ST—epilepsy syndrome	3.28e-05	0.000167	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—JUNB—epilepsy syndrome	3.25e-05	0.000165	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CNR1—epilepsy syndrome	3.25e-05	0.000165	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR2—epilepsy syndrome	3.24e-05	0.000165	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR2—epilepsy syndrome	3.24e-05	0.000165	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SST—epilepsy syndrome	3.24e-05	0.000165	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NTRK2—epilepsy syndrome	3.24e-05	0.000165	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NTRK2—epilepsy syndrome	3.24e-05	0.000165	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SST—epilepsy syndrome	3.24e-05	0.000165	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PLCB1—epilepsy syndrome	3.24e-05	0.000164	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—DUSP6—epilepsy syndrome	3.21e-05	0.000163	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—DUSP6—epilepsy syndrome	3.21e-05	0.000163	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRA2A—epilepsy syndrome	3.17e-05	0.000161	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRA2A—epilepsy syndrome	3.17e-05	0.000161	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR7—epilepsy syndrome	3.17e-05	0.000161	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AGT—epilepsy syndrome	3.17e-05	0.000161	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PLAT—epilepsy syndrome	3.16e-05	0.00016	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PLAT—epilepsy syndrome	3.16e-05	0.00016	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.16e-05	0.00016	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—SRC—epilepsy syndrome	3.11e-05	0.000158	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—APOE—epilepsy syndrome	3.1e-05	0.000158	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HBEGF—epilepsy syndrome	3.08e-05	0.000156	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—BDKRB2—epilepsy syndrome	3.05e-05	0.000155	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—BDKRB2—epilepsy syndrome	3.05e-05	0.000155	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL12—epilepsy syndrome	3.05e-05	0.000155	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL12—epilepsy syndrome	3.05e-05	0.000155	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—POMC—epilepsy syndrome	3.04e-05	0.000154	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—POMC—epilepsy syndrome	3.04e-05	0.000154	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PRKCB—epilepsy syndrome	3.03e-05	0.000154	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PRKCB—epilepsy syndrome	3.03e-05	0.000154	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VEGFA—epilepsy syndrome	3.03e-05	0.000154	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT3—epilepsy syndrome	3.02e-05	0.000153	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6ST—epilepsy syndrome	3.02e-05	0.000153	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6ST—epilepsy syndrome	3.02e-05	0.000153	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—POMC—epilepsy syndrome	3e-05	0.000152	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—JUNB—epilepsy syndrome	2.99e-05	0.000152	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—JUNB—epilepsy syndrome	2.99e-05	0.000152	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CNR1—epilepsy syndrome	2.99e-05	0.000152	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CNR1—epilepsy syndrome	2.99e-05	0.000152	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PLCB1—epilepsy syndrome	2.98e-05	0.000151	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PLCB1—epilepsy syndrome	2.98e-05	0.000151	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	2.97e-05	0.000151	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CERS1—epilepsy syndrome	2.97e-05	0.000151	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	2.97e-05	0.000151	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PDXK—epilepsy syndrome	2.97e-05	0.000151	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADK—epilepsy syndrome	2.97e-05	0.000151	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—FAR1—epilepsy syndrome	2.97e-05	0.000151	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADAM10—epilepsy syndrome	2.95e-05	0.00015	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL2—epilepsy syndrome	2.94e-05	0.000149	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR7—epilepsy syndrome	2.92e-05	0.000148	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR7—epilepsy syndrome	2.92e-05	0.000148	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HBEGF—epilepsy syndrome	2.83e-05	0.000144	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HBEGF—epilepsy syndrome	2.83e-05	0.000144	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGF2—epilepsy syndrome	2.82e-05	0.000143	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—S100B—epilepsy syndrome	2.79e-05	0.000142	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT3—epilepsy syndrome	2.78e-05	0.000141	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT3—epilepsy syndrome	2.78e-05	0.000141	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SOCS3—epilepsy syndrome	2.76e-05	0.00014	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—POMC—epilepsy syndrome	2.76e-05	0.00014	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—POMC—epilepsy syndrome	2.76e-05	0.00014	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDC42—epilepsy syndrome	2.76e-05	0.00014	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PNPO—epilepsy syndrome	2.72e-05	0.000138	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	2.72e-05	0.000138	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GAMT—epilepsy syndrome	2.72e-05	0.000138	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	2.72e-05	0.000138	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADAM10—epilepsy syndrome	2.72e-05	0.000138	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADAM10—epilepsy syndrome	2.72e-05	0.000138	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL2—epilepsy syndrome	2.7e-05	0.000137	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL2—epilepsy syndrome	2.7e-05	0.000137	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AVP—epilepsy syndrome	2.67e-05	0.000136	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—POMC—epilepsy syndrome	2.67e-05	0.000135	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—S100B—epilepsy syndrome	2.57e-05	0.00013	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—S100B—epilepsy syndrome	2.57e-05	0.00013	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MTOR—epilepsy syndrome	2.56e-05	0.00013	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SOCS3—epilepsy syndrome	2.54e-05	0.000129	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SOCS3—epilepsy syndrome	2.54e-05	0.000129	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—epilepsy syndrome	2.54e-05	0.000129	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDC42—epilepsy syndrome	2.54e-05	0.000129	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDC42—epilepsy syndrome	2.54e-05	0.000129	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CA4—epilepsy syndrome	2.53e-05	0.000128	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—QDPR—epilepsy syndrome	2.53e-05	0.000128	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HES1—epilepsy syndrome	2.52e-05	0.000128	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	2.52e-05	0.000128	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AVP—epilepsy syndrome	2.46e-05	0.000125	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AVP—epilepsy syndrome	2.46e-05	0.000125	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FYN—epilepsy syndrome	2.45e-05	0.000125	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—H2AFX—epilepsy syndrome	2.45e-05	0.000124	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MEF2C—epilepsy syndrome	2.44e-05	0.000124	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ALB—epilepsy syndrome	2.43e-05	0.000123	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—COX3—epilepsy syndrome	2.38e-05	0.000121	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—YWHAZ—epilepsy syndrome	2.36e-05	0.00012	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NGF—epilepsy syndrome	2.33e-05	0.000118	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HES1—epilepsy syndrome	2.32e-05	0.000118	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HES1—epilepsy syndrome	2.32e-05	0.000118	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCR5—epilepsy syndrome	2.27e-05	0.000115	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FYN—epilepsy syndrome	2.26e-05	0.000115	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FYN—epilepsy syndrome	2.26e-05	0.000115	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PFKL—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—H2AFX—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—H2AFX—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MEF2C—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MEF2C—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR2A—epilepsy syndrome	2.22e-05	0.000113	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.2e-05	0.000112	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.19e-05	0.000111	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—YWHAZ—epilepsy syndrome	2.17e-05	0.00011	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.17e-05	0.00011	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NGF—epilepsy syndrome	2.15e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NGF—epilepsy syndrome	2.15e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—epilepsy syndrome	2.13e-05	0.000108	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TSC2—epilepsy syndrome	2.11e-05	0.000107	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AGT—epilepsy syndrome	2.11e-05	0.000107	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—AKT1—epilepsy syndrome	2.1e-05	0.000106	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR5—epilepsy syndrome	2.09e-05	0.000106	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR5—epilepsy syndrome	2.09e-05	0.000106	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APOE—epilepsy syndrome	2.06e-05	0.000105	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NEU1—epilepsy syndrome	2.06e-05	0.000105	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—UPB1—epilepsy syndrome	2.06e-05	0.000105	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ATIC—epilepsy syndrome	2.06e-05	0.000105	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SRC—epilepsy syndrome	2.05e-05	0.000104	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR2A—epilepsy syndrome	2.04e-05	0.000104	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR2A—epilepsy syndrome	2.04e-05	0.000104	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—KDR—epilepsy syndrome	2.02e-05	0.000103	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.98e-05	0.000101	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRKCB—epilepsy syndrome	1.95e-05	9.89e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TSC2—epilepsy syndrome	1.94e-05	9.86e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TSC2—epilepsy syndrome	1.94e-05	9.86e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6ST—epilepsy syndrome	1.94e-05	9.85e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AGT—epilepsy syndrome	1.94e-05	9.85e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AGT—epilepsy syndrome	1.94e-05	9.85e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—AKT1—epilepsy syndrome	1.93e-05	9.8e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.92e-05	9.73e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.92e-05	9.73e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APOE—epilepsy syndrome	1.9e-05	9.65e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APOE—epilepsy syndrome	1.9e-05	9.65e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.87e-05	9.51e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KDR—epilepsy syndrome	1.86e-05	9.45e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—KDR—epilepsy syndrome	1.86e-05	9.45e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.8e-05	9.15e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRKCB—epilepsy syndrome	1.79e-05	9.1e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRKCB—epilepsy syndrome	1.79e-05	9.1e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6ST—epilepsy syndrome	1.78e-05	9.06e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6ST—epilepsy syndrome	1.78e-05	9.06e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—epilepsy syndrome	1.77e-05	9.01e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.75e-05	8.9e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL2—epilepsy syndrome	1.74e-05	8.81e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.71e-05	8.67e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.71e-05	8.67e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—epilepsy syndrome	1.63e-05	8.29e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—epilepsy syndrome	1.63e-05	8.29e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.63e-05	8.27e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.63e-05	8.27e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL2—epilepsy syndrome	1.6e-05	8.11e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL2—epilepsy syndrome	1.6e-05	8.11e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.59e-05	8.09e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF2—epilepsy syndrome	1.57e-05	7.96e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.56e-05	7.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.53e-05	7.78e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.5e-05	7.63e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RELA—epilepsy syndrome	1.46e-05	7.39e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF2—epilepsy syndrome	1.44e-05	7.33e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF2—epilepsy syndrome	1.44e-05	7.33e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MTOR—epilepsy syndrome	1.43e-05	7.25e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.41e-05	7.14e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.37e-05	6.93e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RELA—epilepsy syndrome	1.34e-05	6.8e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RELA—epilepsy syndrome	1.34e-05	6.8e-05	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AKT1—epilepsy syndrome	1.33e-05	6.73e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MTOR—epilepsy syndrome	1.31e-05	6.67e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MTOR—epilepsy syndrome	1.31e-05	6.67e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CASP3—epilepsy syndrome	1.31e-05	6.67e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.31e-05	6.66e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—AKT1—epilepsy syndrome	1.28e-05	6.48e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—JUN—epilepsy syndrome	1.28e-05	6.48e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—epilepsy syndrome	1.24e-05	6.3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.23e-05	6.27e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.23e-05	6.27e-05	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.22e-05	6.19e-05	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AKT1—epilepsy syndrome	1.22e-05	6.19e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CASP3—epilepsy syndrome	1.21e-05	6.14e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CASP3—epilepsy syndrome	1.21e-05	6.14e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AKT1—epilepsy syndrome	1.2e-05	6.11e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—JUN—epilepsy syndrome	1.17e-05	5.96e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—JUN—epilepsy syndrome	1.17e-05	5.96e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.15e-05	5.84e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SRC—epilepsy syndrome	1.14e-05	5.81e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—epilepsy syndrome	1.14e-05	5.8e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—epilepsy syndrome	1.14e-05	5.8e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.13e-05	5.72e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—epilepsy syndrome	1.11e-05	5.66e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AKT1—epilepsy syndrome	1.11e-05	5.62e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AKT1—epilepsy syndrome	1.11e-05	5.62e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AKT1—epilepsy syndrome	1.07e-05	5.43e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SRC—epilepsy syndrome	1.05e-05	5.35e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SRC—epilepsy syndrome	1.05e-05	5.35e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—epilepsy syndrome	1.03e-05	5.21e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—epilepsy syndrome	1.03e-05	5.21e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.01e-05	5.11e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	9.81e-06	4.98e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	9.75e-06	4.95e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.68e-06	4.91e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.82e-06	4.48e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	8.8e-06	4.47e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	8.37e-06	4.25e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—BCHE—epilepsy syndrome	8.34e-06	4.23e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	7.96e-06	4.04e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	7.87e-06	4e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TH—epilepsy syndrome	7.84e-06	3.98e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.72e-06	3.92e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT1—epilepsy syndrome	7.11e-06	3.61e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	6.54e-06	3.32e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT1—epilepsy syndrome	6.54e-06	3.32e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT1—epilepsy syndrome	6.54e-06	3.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAT—epilepsy syndrome	6.46e-06	3.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	6.28e-06	3.19e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GPX1—epilepsy syndrome	5.84e-06	2.96e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AGT—epilepsy syndrome	5.12e-06	2.6e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOE—epilepsy syndrome	5.02e-06	2.55e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—epilepsy syndrome	4.31e-06	2.19e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.93e-06	1.99e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.44e-06	1.75e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.73e-06	8.77e-06	CbGpPWpGaD
